22 related articles for article (PubMed ID: 6944206)
1. Excitatory effects of kynurenine and its metabolites, amino acids and convulsants administered into brain ventricles: differences between rats and mice.
Lapin IP; Prakhie IB; Kiseleva IP
J Neural Transm; 1982; 54(3-4):229-38. PubMed ID: 7130975
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of seizures induced by the administration of the endogenous convulsant quinolinic acid into rat brain ventricles.
Lapin IP; Prakhie IB; Kiseleva IP
J Neural Transm; 1986; 65(3-4):177-85. PubMed ID: 2940335
[TBL] [Abstract][Full Text] [Related]
3. [Increase in the activity of an epileptogenic focus in frog hippocampus as a result of kynurenines and its reduction by serotonin].
Gusel' VA; Mikhailov IB
Biull Eksp Biol Med; 1979 Feb; 87(2):158-60. PubMed ID: 311225
[TBL] [Abstract][Full Text] [Related]
4. Effect of tryptophan metabolites on activity of the epileptogenic focus in the frog hippocampus.
Gusel WA; Mikhailov IB
J Neural Transm; 1980; 47(1):41-52. PubMed ID: 6766985
[TBL] [Abstract][Full Text] [Related]
5. [Pharmaco-dynamic mechanisms for reducing the activity of an epileptogenic focus with allopurinol].
Mikhaĭlov IB; Gusel' VA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):870-3. PubMed ID: 6192617
[TBL] [Abstract][Full Text] [Related]
6. [Effect of serotoninergic and antiserotoninergic preparations on convulsions induced by the endogenous convulsants kynurenine and quinolinic acid].
Lapin IP
Farmakol Toksikol; 1987; 50(5):15-8. PubMed ID: 2961608
[TBL] [Abstract][Full Text] [Related]
7. [Effect of gamma-aminobutyric acid and its derivatives on convulsions induced by L-kynurenine and quinolinic acid].
Ryzhov IV; Lapin IP
Farmakol Toksikol; 1981; 44(2):140-3. PubMed ID: 6456152
[TBL] [Abstract][Full Text] [Related]
8. New insights into tryptophan and its metabolites in the regulation of bone metabolism.
Michalowska M; Znorko B; Kaminski T; Oksztulska-Kolanek E; Pawlak D
J Physiol Pharmacol; 2015 Dec; 66(6):779-91. PubMed ID: 26769827
[TBL] [Abstract][Full Text] [Related]
9. [Kynurenine and its metabolites in nervous system diseases].
Vécsei L; Schwab F
Orv Hetil; 1992 Jul; 133(29):1803-7. PubMed ID: 1386152
[TBL] [Abstract][Full Text] [Related]
10. The kynurenine pathway of tryptophan degradation as a drug target.
Schwarcz R
Curr Opin Pharmacol; 2004 Feb; 4(1):12-7. PubMed ID: 15018833
[TBL] [Abstract][Full Text] [Related]
11. [Changes in the activity of an epileptogenic focus in the hippocampus of rats treated with the chief metabolites of tryptophan].
Mikhaĭlov IB
Farmakol Toksikol; 1981; 44(2):143-6. PubMed ID: 6944206
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
